Results 131 to 140 of about 10,338 (183)

Transplacental Flecainide and/or Digoxin for Fetal Tachyarrhythmias: Therapeutic Efficacy and Clinical Experience

open access: yesPrenatal Diagnosis, Volume 46, Issue 12, Page 1991-2002, November 2026.
ABSTRACT Objective To assess the efficacy and safety of transplacental flecainide and/or digoxin for fetal tachyarrhythmias when sotalol is unavailable. Method We evaluated transplacental flecainide, digoxin, or combination therapy in a retrospective and prospective cohort across two Thai tertiary centers.
Mukpradab Darakamas   +6 more
wiley   +1 more source

Multitarget Regulatory Mechanisms and Research Advances of Plant‐Derived Bioactive Ingredients in Hypertension Prevention and Management

open access: yesPhytotherapy Research, Volume 40, Issue 11, Page 6173-6200, November 2026.
Schematic overview of the multi‐target and multi‐pathway mechanisms of PDBI in the prevention and management of hypertension. ABSTRACT Hypertension remains a major global risk factor for cardiovascular diseases, yet current treatments face challenges such as suboptimal blood pressure control and inadequate organ protection.
Qiqi Deng   +6 more
wiley   +1 more source

A higher peak heart rate during head-up tilt test predicts the therapeutic efficacy of metoprolol in vasovagal syncope

open access: yesBMC Cardiovascular Disorders
Background Although beta blockers, such as metoprolol, have been widely used in the management of vasovagal syncope (VVS), their efficacy remains debated, with larger studies showing limited benefit.
Kemei Liu   +8 more
doaj   +1 more source

Restricción de crecimiento intrauterino probablemente asociado al uso de metoprolol: reporte de caso

open access: yesPharmaceutical Care España, 2020
Se presenta el caso de una paciente vinculada al programa de atención prenatal de una entidad promotora de salud (EPS). Se trata de una femenina de 30 años de edad, con embarazo de 20.5 semanas por fecha de última menstruación, con extrasístoles ...
ROXANA DE LAS SALAS   +2 more
doaj  

Göteborg Metoprolol Trial : effects on arrhythmias

open access: yes, 1984
During the initial hospitalization, ventricular fibrillation (VF) developed in 6 metoprolol-treated patients (0.9%) vs 17 placebo-treated patients (2.4%) after inclusion in the study (p = 0.035).
Edwardsson, N   +7 more
core  

Changes in symptoms among the patients responded to metoprolol.

open access: yes, 2015
Changes in symptoms among the patients responded to metoprolol.
Yuli Wang (103182)   +9 more
core   +1 more source

Integrative Approaches in Cardiovascular Disease: The Role of Nutraceuticals in Heart Failure, Atrial Fibrillation, and Related Conditions

open access: yesPhytotherapy Research, Volume 40, Issue 11, Page 6249-6275, November 2026.
Schematic representation of the shared pathophysiological mechanisms underlying heart failure (HF) and atrial fibrillation (AF), including inflammation, oxidative stress, endothelial dysfunction, and fibrosis. The figure highlights the clinical and mechanistic convergence of conventional pharmacological therapies and selected nutraceuticals in ...
Laura Beatrice Mattioli   +6 more
wiley   +1 more source

Angiogenic biomarker concentrations and their relation to coronary atherosclerosis in women with a history of preeclampsia: Findings from the CPH‐PRECIOUS study

open access: yesActa Obstetricia et Gynecologica Scandinavica, Volume 105, Issue 11, Page 2195-2204, November 2026.
This study demonstrates that women with prior preeclampsia had significantly higher concentrations of PlGF when CT‐assessed coronary atherosclerosis was present years following the index pregnancy, whereas no difference was found for concentrations of sFlt‐1.
Signe Højstrup Bessing   +11 more
wiley   +1 more source

Serum Concentration Relationships of Candesartan in Migraine Prevention

open access: yesBasic &Clinical Pharmacology &Toxicology, Volume 139, Issue 5, November 2026.
ABSTRACT Migraine is a common disabling disorder, and optimising affordable preventive treatments remains highly relevant. Candesartan is an effective and well‐tolerated preventive treatment, but little is known about its dose‐concentration–response relationships.
Hedda Skogum Riise   +13 more
wiley   +1 more source

Impact of the ultrarapid metabolizer genotype of cytochrome P450 2D6 on metoprolol pharmacokinetics and pharmacodynamics

open access: yes, 2004
Introduction: In the treatment of heart failure and hypertension with metoprolol, ultrarapid metabolizers (UMs) may not achieve optimal target concentrations with recommended doses.
Seringer, A.   +19 more
core   +1 more source

Home - About - Disclaimer - Privacy